ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 160 filers reported holding ANI PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 6.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $1,301,000 | -22.1% | 23,006 | -8.0% | 0.35% | -25.2% |
| Q2 2018 | $1,670,000 | +14.7% | 25,007 | 0.0% | 0.46% | +12.6% |
| Q1 2018 | $1,456,000 | -22.1% | 25,007 | -13.8% | 0.41% | -17.1% |
| Q4 2017 | $1,870,000 | +22.8% | 29,009 | +0.0% | 0.50% | +21.8% |
| Q3 2017 | $1,523,000 | +25.1% | 29,007 | +11.5% | 0.41% | +23.2% |
| Q2 2017 | $1,217,000 | +55.4% | 26,005 | +64.5% | 0.33% | +71.1% |
| Q1 2017 | $783,000 | -18.3% | 15,805 | 0.0% | 0.19% | -14.2% |
| Q4 2016 | $958,000 | -8.7% | 15,805 | 0.0% | 0.23% | -6.6% |
| Q3 2016 | $1,049,000 | +13.2% | 15,805 | -4.8% | 0.24% | +7.1% |
| Q2 2016 | $927,000 | +111.6% | 16,605 | +27.7% | 0.23% | +89.9% |
| Q1 2016 | $438,000 | -15.6% | 13,005 | +13.0% | 0.12% | -8.5% |
| Q4 2015 | $519,000 | +19.0% | 11,505 | +12.7% | 0.13% | +12.1% |
| Q3 2015 | $436,000 | -15.0% | 10,205 | +10.9% | 0.12% | -35.9% |
| Q2 2015 | $513,000 | +7.8% | 9,204 | +20.9% | 0.18% | -2.7% |
| Q1 2015 | $476,000 | – | 7,615 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 200,000 | $13,270,000 | 21.02% |
| Healthcare Value Capital, LLC | 50,000 | $3,318,000 | 5.26% |
| Consonance Capital Management LP | 653,258 | $43,344,000 | 4.17% |
| 1492 Capital Management LLC | 34,500 | $2,289,000 | 1.87% |
| JW Asset Management, LLC | 29,722 | $1,972,000 | 1.36% |
| FRANKLIN STREET ADVISORS INC /NC | 29,000 | $1,924,000 | 0.35% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 55,705 | $3,696,000 | 0.27% |
| Ativo Capital Management LLC | 15,805 | $1,049,000 | 0.24% |
| DIKER MANAGEMENT LLC | 9,810 | $651,000 | 0.23% |
| CASTLEARK MANAGEMENT LLC | 100,615 | $6,676,000 | 0.20% |